Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008103', 'term': 'Liver Cirrhosis'}, {'id': 'D006528', 'term': 'Carcinoma, Hepatocellular'}, {'id': 'D012008', 'term': 'Recurrence'}], 'ancestors': [{'id': 'D008107', 'term': 'Liver Diseases'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D005355', 'term': 'Fibrosis'}, {'id': 'D010335', 'term': 'Pathologic Processes'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}, {'id': 'D000230', 'term': 'Adenocarcinoma'}, {'id': 'D002277', 'term': 'Carcinoma'}, {'id': 'D009375', 'term': 'Neoplasms, Glandular and Epithelial'}, {'id': 'D009370', 'term': 'Neoplasms by Histologic Type'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D008113', 'term': 'Liver Neoplasms'}, {'id': 'D004067', 'term': 'Digestive System Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D020969', 'term': 'Disease Attributes'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'DIAGNOSTIC', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 72}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2011-10', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2023-11', 'completionDateStruct': {'date': '2022-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-11-21', 'studyFirstSubmitDate': '2011-09-26', 'studyFirstSubmitQcDate': '2011-10-04', 'lastUpdatePostDateStruct': {'date': '2023-11-22', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2011-10-06', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2022-12', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Number of patients who experienced HCC recurrence after RFA', 'timeFrame': 'within 2 years after RFA procedure', 'description': 'To see whether MRE score reflecting hepatic fibrosis predicts the recurrence of HCC within 2 years after RFA treatment'}], 'secondaryOutcomes': [{'measure': 'Sensitivity and specificity of each indicator of hepatic fibrosis compared to the gold-standard histology score', 'timeFrame': '2 years after RFA', 'description': 'To find efficacy of each indicator (MRE, noninvasive serum markers such as APRI, P2/MS) compared to the gold-standard histology score in predicting hepatic fibrosis'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Hepatic fibrosis', 'Magnetic resonance elastography', 'Hepatocellular carcinoma', 'Recurrence'], 'conditions': ['Hepatic Fibrosis', 'Hepatocellular Carcinoma']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to determine:\n\n* The efficacy of MRE score as a predictor of HCC recurrence within 2 years after RFA treatment\n* The efficacy of each indicator (MRE score, non-invasive serum markers) compared to the gold-standard histology score predicting hepatic fibrosis', 'detailedDescription': 'To evaluate whether MRE score reflecting hepatic fibrosis can predict the recurrence of HCC within 2 years after RFA treatment\n\n* Local recurrence/intrahepatic distant recurrence\n* Multivariable analysis including several related factors to find whether MRE score is an independent predictor of HCC recurrence even after adjusting other factors (etiology of liver disease, size of HCC, vessel invasion, HBsAg titer, etc.)\n\nTo find the efficacy of each indicator (MRE score, non-invasive serum markers) compared to the gold-standard histology score predicting hepatic fibrosis.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '80 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Diagnosed as single hypervascular hepatocellular carcinoma initially\n* AJCC stage I HCC\n* Child-Pugh class A\n* Planning radiofrequency ablation for HCC\n* Voluntary agreement for this study\n\nExclusion Criteria:\n\n* Decreased kidney function (GFR \\< 70 mL/min/kg)\n* Contraindication to MRI (pacemaker, defibrillator)\n* Contrast media hypersensitivity\n* Other primary malignancy\n* Acute viral hepatitis\n* Prior history of liver transplantation\n* Thrombosis in splenic vein or portal vein\n* Patients who were enrolled to other clinical trials within 4 weeks\n* Other severe chronic disease or psychiatric disease\n* Pregnant or milk-feeding women\n* Patients with coagulopathy, high risk of bleeding for the liver biopsy\n* Patients who disagree to participate in this study'}, 'identificationModule': {'nctId': 'NCT01447667', 'acronym': 'MRE', 'briefTitle': 'Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)', 'organization': {'class': 'OTHER', 'fullName': 'Seoul National University Hospital'}, 'officialTitle': 'Magnetic Resonance Elastography Score Reflecting Hepatic Fibrosis as an Independent Predictor for Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy', 'orgStudyIdInfo': {'id': 'MRE'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Magnetic resonance elastography', 'description': 'Magnetic resonance elastography before radiofrequency ablation therapy will be performed.', 'interventionNames': ['Procedure: Magnetic resonance elastography']}], 'interventions': [{'name': 'Magnetic resonance elastography', 'type': 'PROCEDURE', 'description': 'Magnetic resonance elastography before RFA and Liver biopsy of 2 HCC tissue and 2 non tumor liver parenchyma tissue', 'armGroupLabels': ['Magnetic resonance elastography']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Seoul', 'country': 'South Korea', 'facility': 'Seoul National University Hospital', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}], 'overallOfficials': [{'name': 'Jung-Hwan Yoon, M.D., Ph.D.', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Seoul National University Hospital'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Seoul National University Hospital', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Clinical professor, M.D., Ph.D.', 'investigatorFullName': 'Jung-Hwan Yoon', 'investigatorAffiliation': 'Seoul National University Hospital'}}}}